IMA Clinical Research Hoboken

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Alzheimer disease

Running trials

• Active, not recruiting

  A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

  NCT05026866· Phase 3· Eli Lilly and Company· Source